Search results
Results From The WOW.Com Content Network
Potassium carbonate is the inorganic compound with the formula K 2 C O 3.It is a white salt, which is soluble in water and forms a strongly alkaline solution. It is deliquescent, often appearing as a damp or wet solid.
This is a list of CAS numbers by chemical formulas and chemical compounds, indexed by formula.The CAS number is a unique number applied to a specific chemical by the Chemical Abstracts Service (CAS).This list complements alternative listings to be found at list of inorganic compounds and glossary of chemical formulae
It also maintains List I of chemicals and List II of chemicals, which contain chemicals that are used to manufacture the controlled substances/illicit drugs. The list is designated within the Controlled Substances Act [ 1 ] but can be modified by the U.S. Attorney General as illegal manufacturing practices change.
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs , ranked by sales.
Ammonium cerium(IV) nitrate – [NH 4] 2 [Ce(NO 3) 6] Ammonium cerium(IV) sulfate – [NH 4] 4 [Ce(SO 4) 4] Ammonium chloride – [NH 4]Cl [39] Ammonium chlorate – [NH 4]ClO 3 [40] Ammonium cyanide – [NH 4]CN [41] Ammonium dichromate – [NH 4] 2 Cr 2 O 7 [42] Ammonium dihydrogen phosphate – [NH 4]H 2 PO 4; Ammonium hexafluoroaluminate ...
The drug or other substance has a currently [1] accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence. The complete list of Schedule III substances is as follows.
This list is ordered by the number of carbon atoms in a carboxylic acid. C1. IUPAC name: Common name: Structural formula Notes formic acid: methanoic acid: HCO 2 H
This list of pharmaceutical compound number prefixes provides codes used by individual pharmaceutical companies when naming their pharmaceutical drug candidates. . Pharmaceutical companies generally produce large numbers of compounds in the research phase for which it is impractical to use often long and cumbersome systematic chemical names, and for which the effort to generate nonproprietary ...